| abstract |
In the present specification, compounds having spiro structure characteristics are described. The present specification also describes a method for producing the above compound, a method for using the above compound for modulating steroid hormone nuclear receptor activity, and a pharmaceutical composition and medicament containing the above compound. Also described herein are methods for using the above compounds, pharmaceutical compositions and medicaments for treating and / or preventing diseases or conditions associated with the activity of steroid hormone nuclear receptors. |